ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

Adding Aresenic To Therapy Improves APL Survival

July 27, 2007

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

In Brief: IOM Cancer Policy Forum names six at-large members

August 1, 2014

Afinitor Extends PFS In Women With EGFR-2 Positive Disease

June 28, 2013

Group Urges Journals To Run Corrections For I-ELCAP Papers.

January 25, 2008

In Brief: Bertino Moves To MSK As Head Of Chemotherapy Research; Rosemary Clive Laves ACOS For Elm

January 2, 1987